Company Filing History:
Years Active: 2005
Title: Zhenkai Ding: Innovator in Endothelin Antagonism
Introduction
Zhenkai Ding is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of endothelin antagonists. His work focuses on innovative solutions for diseases associated with endothelin, showcasing his dedication to advancing medical science.
Latest Patents
Zhenkai Ding holds 1 patent for his invention related to endothelin antagonism. The patent describes a process for preparing tripeptide derivatives that exhibit activity against endothelin. This invention also includes pharmaceutical compositions containing these derivatives and outlines their potential use in the prevention or treatment of diseases linked to endothelin.
Career Highlights
Zhenkai Ding is affiliated with the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences. His role at this esteemed institution allows him to engage in cutting-edge research and contribute to the development of new therapeutic strategies.
Collaborations
Throughout his career, Zhenkai Ding has collaborated with notable colleagues, including Keliang Liu and Wensheng Yu. These partnerships enhance the research environment and foster innovation in the field of pharmacology.
Conclusion
Zhenkai Ding's work in developing endothelin antagonists represents a significant advancement in medical research. His contributions are vital for the ongoing efforts to combat diseases associated with endothelin, and his innovative spirit continues to inspire future research endeavors.